Evidence map›Paper›PMID 37302561›Full record

ArticleRegulatory toxicology and pharmacology : RTP2023

Workshop report: Challenges faced in developing inhalation thresholds of Toxicological Concern (TTC) - State of the science and next steps.

Anthony M Bowden, Sylvia E Escher, Jane Rose, Nikaeta Sadekar, Grace Patlewicz, Lara O'Keeffe, Dagmar Bury, Nicola J Hewitt, Arianna Giusti, Helga Rothe

Abstract read
In one paragraph

Article in Regulatory toxicology and pharmacology : RTP, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anthony M BowdenSafety and Environmental Assurance Centre, Unilever, Colworth Science Park, Sharnbrook, UK. Electronic address: anthony.bowden@unilever.com.
Sylvia E EscherFraunhofer ITEM, Hannover, Germany.
Jane RoseProcter & Gamble, Mason, OH, USA.
Nikaeta SadekarResearch Institute for Fragrance Materials, Inc., Mahwah, NJ, USA.
Grace PatlewiczCenter for Computational and Exposure, US Environmental Protection Agency, RTP, NC, 27711, USA.
Lara O'KeeffeProcter & Gamble, Mason, OH, USA.
Dagmar BuryL'Oréal Research & Innovation, Clichy, France.
Nicola J HewittCosmetics Europe, Brussels, Belgium.
Arianna GiustiCosmetics Europe, Brussels, Belgium.
Helga RotheSciConT (formerly at Coty), Darmstadt, Germany.

Funding

Intramural EPA EPA999999
6 · The paper itself

Abstract

A challenging step in human risk assessment of chemicals is the derivation of safe thresholds. The Threshold of Toxicological Concern (TTC) concept is one option which can be used for the safety evaluation of substances with a limited toxicity dataset, but for which exposure is sufficiently low. The application of the TTC is generally accepted for orally or dermally exposed cosmetic ingredients; however, these values cannot directly be applied to the inhalation route because of differences in exposure route versus oral and dermal. Various approaches of an inhalation TTC concept have been developed over recent years to address this. A virtual workshop organized by Cosmetics Europe, held in November 2020, shared the current state of the science regarding the applicability of existing inhalation TTC approaches to cosmetic ingredients. Key discussion points included the need for an inhalation TTC for local respiratory tract effects in addition to a systemic inhalation TTC, dose metrics, database building and quality of studies, definition of the chemical space and applicability domain, and classification of chemicals with different potencies. The progress made to date in deriving inhalation TTCs was highlighted, as well as the next steps envisaged to develop them further for regulatory acceptance and use.

Indexed as

CosmeticsEuropeHumansNo-Observed-Adverse-Effect LevelRespiratory SystemRisk AssessmentCosmeticsCosmetic ingredientsInhalationRisk assessmentThreshold of toxicological concernWorkshop

Identifiers

PMID37302561
PMCPMC10494708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.